Life Science Company News

Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

WellCare of Kentucky Held Fourth Annual Community Health Champions Awards, Recognizing Individuals Helping to Support Healthy Communities Across the Commonwealth

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Artera Continues to Expand Executive Team & Attract Top Talent

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Trulieve Announces Purchase of 8% Senior Secured Notes due 2026

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

IntraCare Premier ACO continues to lead Dallas-Fort Worth with Exceptional Savings Rates

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Biologics Manufacturing Leads the Way: Insights into the Global Pharmaceutical Contract Manufacturing Market to 2028

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

COSMOSS Partners With Chopra Foundation 'Never Alone' to Support Mental Health Awareness

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Rising Importance of Semen Testing: Global Animal Genetics Market Sees Potential in Fertility Enhancement for Commercial Farms

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Eli Lilly, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

CAAN AND GILEAD SCIENCES CANADA IGNITE HOPE WITH NEW INDIGENOUS HEALTH GRANT

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

GLUCODOWN® Brand Achieves 10,000 Top Reviews at Amazon

Read more ››
By: GlobeNewswire - 21 Sep 2023

Affimed to Present at the Cantor Global Healthcare Conference 2023

Read more ››
By: GlobeNewswire - 21 Sep 2023

Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day

Read more ››
By: GlobeNewswire - 21 Sep 2023

NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimer’s Disease Who Carry an ApoE4 Mutation

Read more ››
By: GlobeNewswire - 21 Sep 2023

Tilray Brands, Inc. to Announce First Quarter 2024 Financial Results on October 4, 2023

Read more ››
By: GlobeNewswire - 21 Sep 2023

Entrada Therapeutics Announces First Participant Dosed in its Phase 1 Clinical Trial of ENTR-601-44 for the Potential Treatment of Duchenne Muscular Dystrophy

Read more ››
By: GlobeNewswire - 21 Sep 2023

Tonix Pharmaceuticals Presents New Preclinical Data at Seventh International Cancer Immunotherapy Conference 2023

Read more ››
By: GlobeNewswire - 21 Sep 2023

Augmedix Announces Inaugural AI Advisory Council Members

Read more ››
By: GlobeNewswire - 21 Sep 2023

Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023

Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missing eGFR Total Slope Endpoint versus Active Control, Irbesartan

Read more ››
By: GlobeNewswire - 21 Sep 2023

Sensei Biotherapeutics Presents New Preclinical Data Reinforcing SNS-101 Pharmacokinetic Profile, Safety Characteristics and Mechanism of Action at the Seventh CRI-ENCI-AACR International Cancer Immunotherapy Conference

Read more ››
By: GlobeNewswire - 21 Sep 2023
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate